These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10600860)

  • 1. Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension.
    Tang X; Mohuczy D; Zhang YC; Kimura B; Galli SM; Phillips MI
    Am J Physiol; 1999 Dec; 277(6):H2392-9. PubMed ID: 10600860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats.
    Makino N; Sugano M; Ohtsuka S; Sawada S; Hata T
    Cardiovasc Res; 1999 Dec; 44(3):543-8. PubMed ID: 10690286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of hypertension and heart hypertrophy by adeno-associated virus delivering angiotensinogen antisense.
    Kimura B; Mohuczy D; Tang X; Phillips MI
    Hypertension; 2001 Feb; 37(2 Pt 2):376-80. PubMed ID: 11230303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged reduction of high blood pressure with an in vivo, nonpathogenic, adeno-associated viral vector delivery of AT1-R mRNA antisense.
    Phillips MI; Mohuczy-Dominiak D; Coffey M; Galli SM; Kimura B; Wu P; Zelles T
    Hypertension; 1997 Jan; 29(1 Pt 2):374-80. PubMed ID: 9039130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central alpha2B-adrenergic receptor antisense in plasmid vector prolongs reversal of salt-dependent hypertension.
    Kintsurashvili E; Johns C; Ignjacev I; Gavras I; Gavras H
    J Hypertens; 2003 May; 21(5):961-7. PubMed ID: 12714871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of plasma angiotensin II to normal levels by antisense oligodeoxynucleotides against liver angiotensinogen cannot completely attenuate vascular remodeling in spontaneously hypertensive rats.
    Sugano M; Tsuchida K; Sawada S; Makino N
    J Hypertens; 2000 Jun; 18(6):725-31. PubMed ID: 10872557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for hypertension: sense and antisense strategies.
    Phillips MI
    Expert Opin Biol Ther; 2001 Jul; 1(4):655-62. PubMed ID: 11727501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense inhibition of AT1 receptor in vascular smooth muscle cells using adeno-associated virus-based vector.
    Mohuczy D; Gelband CH; Phillips MI
    Hypertension; 1999 Jan; 33(1 Pt 2):354-9. PubMed ID: 9931129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension.
    Phillips MI
    Hypertension; 1997 Jan; 29(1 Pt 2):177-87. PubMed ID: 9039099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic gene therapy for hypertension.
    Phillips MI
    Braz J Med Biol Res; 2000 Jun; 33(6):715-21. PubMed ID: 10829100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-mediated RNA interference of angiotensinogen decreases blood pressure and improves myocardial remodeling in spontaneously hypertensive rats.
    Yuan LF; Sheng J; Lu P; Wang YQ; Jin T; Du Q
    Mol Med Rep; 2015 Sep; 12(3):4657-4663. PubMed ID: 26062941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous injection with antisense oligodeoxynucleotides against angiotensinogen decreases blood pressure in spontaneously hypertensive rats.
    Makino N; Sugano M; Ohtsuka S; Sawada S
    Hypertension; 1998 May; 31(5):1166-70. PubMed ID: 9576130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotides against rat angiotensinogen.
    Tomita N; Morishita R; Higaki J; Aoki M; Nakamura Y; Mikami H; Fukamizu A; Murakami K; Kaneda Y; Ogihara T
    Hypertension; 1995 Jul; 26(1):131-6. PubMed ID: 7541778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats.
    Chao J; Jin L; Lin KF; Chao L
    Hypertens Res; 1997 Dec; 20(4):269-77. PubMed ID: 9453262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats.
    Wang C; Chao L; Chao J
    J Clin Invest; 1995 Apr; 95(4):1710-6. PubMed ID: 7535795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hypertension by peripheral administration of antisense oligodeoxynucleotides.
    Wielbo D; Simon A; Phillips MI; Toffolo S
    Hypertension; 1996 Jul; 28(1):147-51. PubMed ID: 8675256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensinogen Exerts Effects Independent of Angiotensin II.
    Lu H; Wu C; Howatt DA; Balakrishnan A; Moorleghen JJ; Chen X; Zhao M; Graham MJ; Mullick AE; Crooke RM; Feldman DL; Cassis LA; Vander Kooi CW; Daugherty A
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):256-65. PubMed ID: 26681751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of hepatic angiotensinogen using chemically modified siRNAs results in significant and sustained blood pressure lowering in a rat model of hypertension.
    Olearczyk J; Gao S; Eybye M; Yendluri S; Andrews L; Bartz S; Cully D; Tadin-Strapps M
    Hypertens Res; 2014 May; 37(5):405-12. PubMed ID: 24335718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer].
    Cheng J; Leng X; Peng J
    Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):461-3. PubMed ID: 11798803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense inhibition of hypertension in the spontaneously hypertensive rat.
    Wielbo D; Sernia C; Gyurko R; Phillips MI
    Hypertension; 1995 Mar; 25(3):314-9. PubMed ID: 7875755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.